1naresh

Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1nareshArray
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)

Table 3: Summary data for 53 patients who underwent percutaneous sacroplasty
Characteristics Data
Total patients 53
Age (mean) (yr) 76.4 ± 2.8
Age younger than 70 yr 13 (25%)
Age 70–79 yr 20 (38%)
Age 80–89 yr 15 (28%)
Age 90 yr or older 5 (9%)
Female 44 (83%)
Female/male ratio 5:1
Cancer-related fracture 29 (55%)
Breast cancer 9/29 (31%)
Multiple myeloma 7/29 (24%)
Colorectal cancer 6/29 (21%)
Small cell lung cancer 2/29 (7%)
Prostate cancer 1/29 (3%)
Melanoma 1/29 (3%)
Cervical cancer 1/29 (3%)
Hematologic malignancy 1/29 (3%)
Pancreatic cancer 1/29 (3%)
Osteoporotic fracture 16 (30%)
Traumatic fracture 8 (15%)
Bilateral fractures treated 44 (83%)
Sacroplasty with conscious sedation 39 (74%)
Sacroplasty under general anesthesia 14 (26%)
Sacroplasty with CT guidance 48 (91%)
Sacroplasty with fluoroscopic guidance 5 (9%)
Significant complications 0
Procedural mortality 0
Time to follow-up (days) 27 (±3.7)